Awareness about Neonatal Lactose Intolerance among Chinese Neonatologists in Outpatient Settings: A Multi-Center Survey
by
Zhengli Wang
1,2,3,4,5,†, 
Liting Liu
1,2,3,4,†,
Chao Yu
6,
Wenyan Tang
5,
Xiangping Ding
5,
Xiangwen Hu
5 and
Yuan Shi
1,2,3,4,5,* 1
Department of Neonatology, Children’s Hospital of Chongqing Medical University, Chongqing 400014, China
2
National Clinical Research Center for Child Health and Disorders, Chongqing 400014, China
3
Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing 400014, China
4
Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing 400014, China
5
Jiangxi Hospital, Children’s Hospital of Chongqing Medical University, Nanchang 330000, China
6
The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College, Chongqing 400016, China
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Children 2024, 11(8), 1014; https://doi.org/10.3390/children11081014
Submission received: 25 July 2024
/
Revised: 14 August 2024
/
Accepted: 16 August 2024
/
Published: 20 August 2024
(This article belongs to the Section Pediatric Neonatology)
Abstract
:Background: This study aimed to identify the specific areas of knowledge gaps regarding lactose intolerance among neonatologists in Chinese outpatient settings as well as to assess the availability of lactose intolerance testing in hospitals. Methods: A total of 278 neonatologists in outpatient settings from 144 hospitals were surveyed. To explore the awareness level, diagnosis, and treatment of neonatal lactose intolerance among neonatologists in outpatient settings, a multicenter cross-sectional survey was designed. Descriptive analysis based on frequency and percent distribution was performed for all variables. Results: Most respondents were senior doctors (256, 92.09%) from general hospitals and maternity/maternal and child health hospitals, had over 10 years of experience, and were dominantly associate chief physicians and chief physicians (211, 75.90%). A significant proportion of the participants (236, 84.89%) believed that neonatal lactose intolerance tends to be overlooked during clinical practice. When the most common symptoms of neonatal lactose intolerance were surveyed, diarrhea was selected by 142 (51.08%) respondents, followed by bloating and milk regurgitation or emesis (71, 25.54%). Other symptoms included unexplained crying (36, 12.85%), stool with milk flap or foam (15, 5.40%), and increased venting (14, 5.04%). Furthermore, the survey results indicated that the most common method for diagnosing neonatal lactose intolerance in the respondents’ hospitals was qualitative test for urinary galactose (78, 28.06%). Of the respondents, 137 (49.28%) stated that their hospital could not test for lactose intolerance. For treating lactose intolerance, the neonatologists primarily opted for exogenous lactase rather than lactose-free formula milk. Conclusions: This study sheds light on Chinese neonatologists’ awareness of neonatal lactose intolerance, revealing some knowledge gaps. The expeditious popularization and conduct of lactose intolerance-related examinations in hospitals will have a positive stimulative effect on the management of lactose intolerance in newborns.
1. Introduction
Neonatal lactose intolerance refers to the deficiency or reduced activity of lactase in the neonatal digestive system, which results in impaired lactose digestion and absorption [1]. The symptoms include diarrhea, abdominal distension, increased bowel sounds, intestinal colic, constipation, and vomiting [2,3]. The manifestations of this condition are varied and lack specificity. Prolonged untreated neonatal lactose intolerance can lead to chronic diarrhea, malnutrition, anemia, osteoporosis, and other long-term risks in newborns [4,5]. Thus, early detection and appropriate intervention are crucial. Currently, available treatment options encompass lactase supplementation and a lactose-free/low-lactose diet [6,7]. Nonetheless, established guidelines are not available for the diagnosis and treatment of neonatal lactose intolerance, particularly in preterm infants [1,8]. At present, it is widely accepted that if an infant is breastfed, breastfeeding should not be discontinued because of lactose intolerance; instead, exogenous lactase supplementation should be considered [9]. Several studies have documented substantial improvement in gastrointestinal symptoms, such as diarrhea, bloating, nausea, and abdominal pain, after oral lactase administration [10,11,12].
Unfortunately, knowledge of neonatal lactose intolerance has not been adequately disseminated, and as a result, many patients remain undiagnosed [13]. In China, neonatologists often encounter cases of neonatal lactose intolerance in outpatient clinics, thereby providing them with a valuable opportunity for prevention and control efforts. Although there is a lack of consensus on specific related aspects. On the one hand, it is imperative to educate parents about lactose intolerance via various means. On the other hand, neonatologists need to augment their understanding [14]. Regrettably, there are no reports on the level of awareness or treatment of lactose intolerance among neonatal outpatient doctors in China.
The level of understanding and awareness among neonatologists regarding the diagnosis and treatment of lactose intolerance, as well as the availability of lactose intolerance testing, may significantly impact the timely management of this condition in newborns. Furthermore, it has come to our attention that several hospitals in China do not offer lactose intolerance testing. Therefore, we hope to identify the specific areas of knowledge gaps regarding lactose intolerance among neonatal doctors as well as to assess the availability of lactose intolerance testing in hospitals. This approach is expected to provide targeted education to neonatologists and advocate the importance of incorporating lactose intolerance testing in healthcare facilities.
2. Materials and Methods
2.1. Study Design and Population
The study was a multicenter online survey conducted between 22 December 2023 and 30 January 2024. We randomly selected 278 neonatologists in outpatient settings from 144 hospitals located in 62 cities spanning 23 provinces and municipalities of China to participate in the survey. We launched this electronic questionnaire survey for neonatologists in outpatient settings through “WeChat group” or face-to-face invitation. Neonatologists in outpatient settings who volunteered to participate in the questionnaire study were included. Doctors from other specialties and neonatologists who did not agree to participate in the survey were excluded. The interviewed neonatologists were assured that the results of the survey would be used only for scientific research, but they were not informed of the specific research contents. The respondents remained anonymous. The study protocol was approved by the institutional ethics committee of the Children’s Hospital of Chongqing Medical University.
2.2. Questionnaires and Data Collection
After conducting a comprehensive literature review and consulting experienced neonatologists, a questionnaire containing 22 questions was developed to understand the knowledge level of neonatologists about neonatal lactose intolerance. The questionnaire was categorized into the following three parts: (1) personal information, including the hospital level, sex, years of working, and professional title of the respondents; (2) awareness of the respondents about neonatal lactose intolerance, including its clinical manifestations, diagnostic methods, and treatment options; and (3) knowledge of the respondents about lactase. The questionnaire was created using the “Wenjuanxing” platform (Changsha Ranxing Information Technology Co., Ltd., Changsha, China). The respondents completed the questionnaire directly on their mobile devices. Before participating in the survey, the study was explained to them, including the sentence “By completing the questionnaire, you are consenting to participate”. Therefore, the respondents who completed the questionnaire were considered to have provided their consent.
2.3. Data Analysis
The data were reviewed separately by members of the research team and were entered into an MS Office Excel file. Descriptive analysis based on frequency and percent distribution was performed for all variables, including data on the participants’ demographic profiles and awareness of lactose intolerance disorder and lactase enzyme. Data processing and analysis were performed using R version 4.3.0 (21 April 2023), along with Zstats v0.90 (https://www.medsta.cn/software, accessed on 21 April 2023). For categorical variables, the proper statistical tests were applied, including the Chi-squared test and Fischer’s exact test. In addition, p < 0.05 was considered to indicate statistical significance.
3. Results
3.1. Demographic Data
The respondents were predominantly senior physicians from tertiary hospitals, and the majority of them had been working for more than 10 years. The detailed characteristics of the respondents are presented in Table 1.
3.2. The Majority of the Respondents of the Respondents Self-Assessed Their Awareness of Neonatal Lactose Intolerance as “Partial Understanding” and Deemed It Prone to Being Ignored in Clinical Work
Among these respondents, 78 (28.06%) were very much aware of neonatal lactose intolerance, 169 (60.79%) were somewhat aware of this condition, and only 1 (0.36%) was not very much aware of it. More than half of the participants (160, 57.55%) indicated that neonatal lactose intolerance accounted for <20% of neonatal outpatients. Approximately one-third of the participants (98, 35.25%) stated that neonatal lactose intolerance accounted for approximately 20–39.99% of neonatal outpatients. The respondents agreed that this disease was more common in preterm infants. Most participants (236, 84.89%) believed that neonatal lactose intolerance tends to be overlooked during clinical practice. When they encountered newborns with diarrhea, bloating, emesis, or unexplained crying, 59 (21.22%) neonatologists stated that they routinely tested for lactose intolerance, whereas 219 (78.78%) did not. These results are given in Table 2.
3.3. The Majority of the Respondents Opined That Neonatal Lactose Intolerance Is Predominantly Developmental Lactose Intolerance with Diarrhea as the Principal Manifestation
When the etiology of neonatal lactose intolerance was surveyed, it was reported to be developmental lactose intolerance by 246 (88.49%) respondents. Furthermore, when the most common symptoms of neonatal lactose intolerance were inquired, diarrhea was selected by 142 (51.08%) respondents (Table 3).
3.4. The Majority of the Respondents Gave Priority to Lactase for the Treatment of Cases of Neonatal Lactose Intolerance
The survey results demonstrated that the most common method for diagnosing neonatal lactose intolerance in the hospitals of the respondents was qualitative testing for urinary galactose (78, 28.06%). About half of the respondents (49.28%) mentioned that their hospital did not test for lactose intolerance. Whenever newborns exhibited lactose intolerance and significant gastrointestinal symptoms, most respondents preferred exogenous lactase supplementation over switching to lactose-free formula milk as an adjunct to conventional symptomatic medications. The findings are elaborated in Table 4.
3.5. The Majority of the Respondents Self-Assessed Their Awareness of Neonatal Lactase Usage in Terms of Indications, Methods, and Treatment Options as “Partial Understanding”
The survey results revealed that most respondents selected “completely understand” or “partly understand” for the question on their awareness of indications, methods, and treatment options for the use of lactase, and only a few respondents indicated a limited understanding. Moreover, 96 (34.53%) respondents stated that prophylactic lactase supplementation can be given to newborns at high risk of lactose intolerance, and 67 (24.1%) respondents indicated that supplementation of lactase should only be administered to newborns diagnosed with lactose intolerance. In addition, 93.88% reported that liquid lactase is suitable for newborns with lactose intolerance. These results are presented in a detailed manner in Table 5.
3.6. More Neonatologists from the Children’s Hospitals Believed That the Duration of the Use of Lactase Was “≥2 Weeks and Symptoms Improved”
No significant differences were noted in the baseline characteristics of neonatologists from three different types of hospitals (i.e., general hospitals, maternity/maternal and child health hospitals, and children’s hospitals), and they were majorly aware of neonatal lactose intolerance. However, their understanding of the duration of lactase use was inconsistent, and more neonatologists from the children’s hospitals believed that the duration of the use of lactase was more than 2 weeks when compared to that of the other two types of hospitals (p = 0.016; Table 6).
4. Discussion
The prevalence of neonatal lactose intolerance in China is approximately 40% and accounts for 12–30% of all children with lactose intolerance [15]. The predominant symptoms of this condition are diarrhea, abdominal distension, increased exhaustion, and colic [2]. However, in a small number of patients, abdominal distension or colic is the only clinical manifestation, and it is difficult to diagnose them; hence, the rate of missed diagnosis is likely to be high. Therefore, this survey aimed to comprehensively assess the awareness status of neonatal lactose intolerance among Chinese neonatologists.
The respondents primarily hailed from general hospitals, maternal and child health hospitals, and children’s hospitals. Most of them held professional titles as chief physicians or associate chief physicians. Although there were certain differences in the views, the overall awareness of the diagnosis and treatment of neonatal lactose intolerance was generally unified. According to a study, lactose intolerance can be categorized into four types: primary lactase deficiency, secondary lactase deficiency, developmental lactase deficiency, and congenital lactase deficiency [16]. Neonatal lactose intolerance is chiefly characterized by developmental and secondary lactase deficiency. Developmental lactase deficiency, also known as relative lactase deficiency, is more common in premature infants because lactase and other disaccharides in the gastrointestinal tract begin to develop rapidly after only 34 weeks of gestation and peak at 40 weeks [17]. This finding is consistent with the opinion of >50% of the respondents that lactose intolerance is more common in preterm infants.
Up to 70% of the global population exhibits lactase non-persistence, but not all individuals are intolerant to lactose due to various nutritional and genetic factors that influence tolerance [18]. Lactose intolerance is characterized by a range of symptoms, such as abdominal pain, bloating, excessive gas, diarrhea, audible bowel sounds, and, occasionally, nausea and vomiting [6]. In rare instances, lactose intolerance can decrease gastrointestinal motility, potentially causing constipation, which may be linked to methane production [19]. In addition to gastrointestinal symptoms, neonatal lactose intolerance can also result in extra-gastrointestinal symptoms, such as oral ulcers, arrhythmias, and eczema [1]. In severe cases, it may also lead to malnutrition, growth retardation, anemia, and abnormal bone metabolism [7]. However, in our survey, several respondents missed these symptoms. This result serves as a reminder to pay more attention to the diverse range of clinical symptoms associated with lactose intolerance in newborns.
The understanding of lactose intolerance varies among different doctors. An international cross-sectional survey focusing on medical professionals for the management of milk protein allergy and lactose intolerance in infants and young children reported that the respondents were confident in managing lactose intolerance; however, there were significant knowledge disparities regarding the differences between food protein allergy and lactose intolerance, as well as marked differences in the level of understanding of relevant clinical practice guidelines [20]. A nationwide survey conducted in Spain compared the knowledge and clinical management of primary care physicians (PCPs) with that of Spanish gastroenterologists (GEs) and discovered that the level of understanding of lactose intolerance was similar. Nevertheless, a higher proportion of PCPs lacked epidemiological awareness (p < 0.01). GEs tended to regard lactose intolerance as a “minor” condition, and the symptoms perceived as suspicious for lactose intolerance were alike in both groups [21]. Although most of the surveyed neonatologists self-assessed that they had a good understanding of lactose intolerance, some respondents had an inadequate awareness of the symptoms, clinical signs, and diagnosis of the disease, which is a key finding of this study. The survey results of this questionnaire are self-assessments, and there may be situations of non-objectivity. Therefore, the further reinforcement of the professional knowledge education for neonatologists and the augmentation of their understanding of the clinical practice guidelines pertaining to the diagnosis and treatment of lactose intolerance might potentially facilitate the enhancement of the clinical outcomes of the pediatric patients.
The examination methods for diagnosing neonatal lactose intolerance include the following: hydrogen breath test, lactose tolerance test, reducing sugar and pH determination in the stool sample, qualitative test for urinary galactose, jejunum mucosal biopsy, and genetic test [22]. The questionnaire survey revealed that reducing sugar and pH determination in the stool sample and qualitative test for urinary galactose were the most common methods for determining lactose intolerance in the hospitals of the respondents. The method of fecal reducing sugar and pH determination is noninvasive, simple, and suitable for neonates. As lactase activity is not completely lost in patients with developmental lactase deficiency, qualitative tests for urinary galactose may yield false negative results. Nonetheless, almost half of the respondents stated that their hospital did not perform tests for diagnosing neonatal lactose intolerance, which is a crucial factor limiting its clinical diagnosis. Inadequate awareness of the manifestations and diagnosis of the condition may prevent neonatologists from providing reasonable advice. However, the sensitivity and specificity of these tests are affected by factors such as reagents, testing methods, and samples, making them unstable [8]. Consequently, relying solely on test results to reach a conclusion may contribute to missed diagnoses [23]. In clinical practice, diagnosing lactose intolerance in newborns involves not only laboratory testing, but also diagnostic treatment based on an initial assessment of clinical symptoms to observe whether the clinical symptoms are alleviated [24].
The management of neonatal lactose intolerance includes approaches such as low-lactose/lactose-free formula milk and lactase supplementation. However, a long-term lactose-free diet prevents the absorption of calcium, iron, and zinc in newborns and may affect their nervous system development [25]. Neonatologists still need to enhance the detailed elaboration to parents on the relevant knowledge regarding the treatment and follow-up of lactose intolerance in order to reduce unnecessary feeding with lactose-free milk powder. A survey on parenting practices among Chinese in Singapore reported that half of the respondents thought that it was necessary to switch to lactose-free formula once a child developed diarrhea, and only 44% felt that pediatricians allocated sufficient time to discuss parenting issues [26]. Moreover, breast milk offers numerous advantages and plays a vital role in the growth and immune regulation of neonates. According to the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children, breastfed infants should be exclusively fed with human milk in all cases [27]. Given the increasing emphasis on breastfeeding, the use of lactose-free formula milk as a substitute for breast milk may not be an ideal choice. Several studies have reported that lactase supplementation can alleviate the symptoms associated with neonatal lactose intolerance, such as reducing the duration of diarrhea and relieving intestinal colic [28,29,30]. Lactase supplementation can enhance weight gain in preterm infants without altering the original dietary structure [11], thus making it an efficacious remedy for neonatal lactose intolerance.
This questionnaire survey revealed that neonatologists from general hospitals, maternity/maternal and child health hospitals, and children’s hospitals shared the same awareness level about neonatal lactose intolerance. More than 90% of neonatologists, especially those from children’s hospitals, opted for exogenous lactase to treat lactose intolerance. A greater proportion of neonatologists from children’s hospitals believed that the duration of treatment was inclined to be ≥2 weeks when compared to the other two types of hospitals. However, proper guidelines on the course and dosage of lactase supplementation are still lacking, and further prospective, multicenter, large-sample clinical studies are needed to validate our findings.
Nonetheless, there are certain limitations in this study. Owing to resource limitations, a strict sampling survey and a large sample survey could not be conducted. The source and number of respondents in this survey were restricted and mainly comprised clinicians with senior professional titles, extensive work experience, and employment in large tertiary hospitals. All respondents voluntarily participated in the survey, and the number of participants from each unit was small. Some of the questions are subjective and may be biased from the actual situation of the respondents. Therefore, the awareness level of Chinese neonatologists regarding neonatal lactose intolerance might not have been completely represented.
5. Conclusions
This study sheds light on Chinese neonatologists’ awareness of neonatal lactose intolerance, revealing some knowledge gaps. The expeditious popularization and conduct of lactose intolerance-related examinations in hospitals will have a positive stimulative effect on the management of lactose intolerance in newborns.
Author Contributions
Conceptualization, Y.S.; data curation, Z.W. and L.L.; formal analysis, W.T., X.D., and X.H.; investigation, Z.W. and L.L.; methodology, Z.W. and L.L.; validation, C.Y.; writing—original draft, Z.W. and L.L. All authors have read and agreed to the published version of the manuscript.
Funding
This research was funded by the National Key Research and Development Program of China, grant number 2022YFC2704803, Technical Innovation and promotion project of Chongqing, grant number CSTC2021jscx-gksb-N0015.
Institutional Review Board Statement
This study has been approved by the institutional ethics committee of the Children’s Hospital of Chongqing Medical University (approval number: 2023-542, approved on 22 December 2023).
Informed Consent Statement
Informed consent was obtained from all subjects involved in this study.
Data Availability Statement
The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.
Acknowledgments
We would like to thank Li Luquan, Bao Lei, and Huang Lie for their consultation and assistance in the preparation of this questionnaire.
Conflicts of Interest
The authors declare no conflicts of interest.
References
- Catanzaro, R.; Sciuto, M.; Marotta, F. Lactose intolerance: An update on its pathogenesis, diagnosis, and treatment. Nutr. Res. 2021, 89, 23–34. [Google Scholar] [CrossRef] [PubMed]
- Bayless, T.M.; Brown, E.; Paige, D.M. Lactase Non-persistence and Lactose Intolerance. Curr. Gastroenterol. Rep. 2017, 19, 23. [Google Scholar] [CrossRef]
- Deng, Y.; Misselwitz, B.; Dai, N.; Fox, M. Lactose Intolerance in Adults: Biological Mechanism and Dietary Management. Nutrients 2015, 7, 8020–8035. [Google Scholar] [CrossRef]
- Tan-Dy, C.R.; Ohlsson, A. Lactase treated feeds to promote growth and feeding tolerance in preterm infants. Cochrane Database Syst. Rev. 2013, 2013, CD004591. [Google Scholar] [CrossRef] [PubMed]
- Suchy, F.J.; Brannon, P.M.; Carpenter, T.O.; Fernandez, J.R.; Gilsanz, V.; Gould, J.B.; Hall, K.; Hui, S.L.; Lupton, J.; Mennella, J.; et al. National Institutes of Health Consensus Development Conference: Lactose intolerance and health. Ann. Intern. Med. 2010, 152, 792–796. [Google Scholar] [CrossRef] [PubMed]
- Misselwitz, B.; Butter, M.; Verbeke, K.; Fox, M.R. Update on lactose malabsorption and intolerance: Pathogenesis, diagnosis and clinical management. Gut 2019, 68, 2080–2091. [Google Scholar] [CrossRef] [PubMed]
- Silberman, E.S.; Jin, J. Lactose Intolerance. JAMA 2019, 322, 1620. [Google Scholar] [CrossRef]
- Marton, A.; Xue, X.; Szilagyi, A. Meta-analysis: The diagnostic accuracy of lactose breath hydrogen or lactose tolerance tests for predicting the North European lactase polymorphism C/T-13910. Aliment. Pharmacol. Ther. 2012, 35, 429–440. [Google Scholar] [CrossRef]
- Suchy, F.J.; Brannon, P.M.; Carpenter, T.O.; Fernandez, J.R.; Gilsanz, V.; Gould, J.B.; Hall, K.; Hui, S.L.; Lupton, J.; Mennella, J.; et al. NIH consensus development conference statement: Lactose intolerance and health. NIH Consens State Sci. Statements 2010, 27, 1–27. [Google Scholar]
- Ibba, I.; Gilli, A.; Boi, M.F.; Usai, P. Effects of exogenous lactase administration on hydrogen breath excretion and intestinal symptoms in patients presenting lactose malabsorption and intolerance. Biomed. Res. Int. 2014, 2014, 680196. [Google Scholar] [CrossRef]
- Erasmus, H.D.; Ludwig-Auser, H.M.; Paterson, P.G.; Sun, D.; Sankaran, K. Enhanced weight gain in preterm infants receiving lactase-treated feeds: A randomized, double-blind, controlled trial. J. Pediatr. 2002, 141, 532–537. [Google Scholar] [CrossRef] [PubMed]
- Wolke, D.; Bilgin, A.; Samara, M. Systematic Review and Meta-Analysis: Fussing and Crying Durations and Prevalence of Colic in Infants. J. Pediatr. 2017, 185, 55–61.e4. [Google Scholar] [CrossRef] [PubMed]
- Baker, S.S. Counseling parents on feeding their children. Curr. Opin. Clin. Nutr. Metab. Care 2007, 10, 355–359. [Google Scholar] [CrossRef]
- Wang, S.; Li, M.; Xiang, X.; Guo, X.; Peng, C.; Wang, D.; Chen, Y. Analysis on the current situation of twin breastfeeding and its influencing factors. Medicine 2023, 102, e35161. [Google Scholar] [CrossRef] [PubMed]
- Yuan, Y.; Cheng, C. Progress in neonatal lactose intolerance. Int. J. Pediatr. 2021, 48, 440. [Google Scholar]
- Heyman, M.B. Committee on Nutrition. Lactose intolerance in infants, children, and adolescents. Pediatrics 2006, 118, 1279–1286. [Google Scholar] [CrossRef]
- Di Rienzo, T.; D’Angelo, G.; D’Aversa, F.; Campanale, M.C.; Cesario, V.; Montalto, M.; Gasbarrini, A.; Ojetti, V. Lactose intolerance: From diagnosis to correct management. Eur. Rev. Med. Pharmacol. Sci. 2013, 17, 18–25. [Google Scholar]
- Lomer, M.C.; Parkes, G.C.; Sanderson, J.D. Review article: Lactose intolerance in clinical practice—Myths and realities. Aliment. Pharmacol. Ther. 2008, 27, 93–103. [Google Scholar] [CrossRef] [PubMed]
- Leszkowicz, J.; Plata-Nazar, K.; Szlagatys-Sidorkiewicz, A. Can Lactose Intolerance Be a Cause of Constipation? A Narrative Review. Nutrients 2022, 14, 1785. [Google Scholar] [CrossRef]
- Madrazo, J.A.; Alrefaee, F.; Chakrabarty, A.; de Leon, J.C.; Geng, L.; Gong, S.; Heine, R.G.; Järvi, A.; Ngamphaiboon, J.; Ong, C.; et al. International Cross-Sectional Survey among Healthcare Professionals on the Management of Cow’s Milk Protein Allergy and Lactose Intolerance in Infants and Children. Pediatr. Gastroent. Hepatol. Nutr. 2022, 25, 263–275. [Google Scholar] [CrossRef]
- Argüelles-Arias, F.; Rodríguez Ledo, P.; Tenías, J.M.; Otero, M.; Casellas, F.; Blay Cortés, G.; Lucendo, A.; Domínguez-Jiménez, J.L.; Carballo, F. The management of lactose intolerance among primary care physicians and its correlation with management by gastroenterologists: The SEPD-SEMG national survey. Rev. Esp. Enferm. Dig. 2015, 107, 554–588. [Google Scholar] [CrossRef] [PubMed]
- Di Costanzo, M.; Berni Canani, R. Lactose Intolerance: Common Misunderstandings. Ann. Nutr. Metab. 2018, 73, 30–37. [Google Scholar] [CrossRef]
- De Geyter, C.; Van de Maele, K.; Hauser, B.; Vandenplas, Y. Hydrogen and Methane Breath Test in the Diagnosis of Lactose Intolerance. Nutrients 2021, 13, 3261. [Google Scholar] [CrossRef]
- Szilagyi, A.; Ishayek, N. Lactose Intolerance, Dairy Avoidance, and Treatment Options. Nutrients 2018, 10, 1994. [Google Scholar] [CrossRef] [PubMed]
- Abrams, S.A.; Griffin, I.J.; Davila, P.M. Calcium and zinc absorption from lactose-containing and lactose-free infant formulas. Am. J. Clin. Nutr. 2002, 76, 442–446. [Google Scholar] [CrossRef] [PubMed]
- Poon, W.B.; Ho, W.L.; Yeo, C.L. Survey on parenting practices among Chinese in Singapore. Singapore Med. J. 2007, 48, 1006–1011. [Google Scholar] [PubMed]
- Guarino, A.; Ashkenazi, S.; Gendrel, D.; Lo Vecchio, A.; Shamir, R.; Szajewska, H.; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition; European Society for Pediatric Infectious Diseases. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: Update 2014. J. Pediatr. Gastroenterol. Nutr. 2014, 59, 132–152. [Google Scholar] [CrossRef]
- Kanabar, D.; Randhawa, M.; Clayton, P. Improvement of symptoms in infant colic following reduction of lactose load with lactase. J. Hum. Nutr. Diet. 2001, 14, 359–363. [Google Scholar] [CrossRef]
- Narang, M.; Shah, D. Oral lactase for infantile colic: A randomized double-blind placebo-controlled trial. BMC Pediatr. 2022, 22, 468. [Google Scholar] [CrossRef]
- Swagerty, D.L., Jr.; Walling, A.D.; Klein, R.M. Lactose intolerance. Am. Fam. Physician 2002, 65, 1845–1850. [Google Scholar]
Table 1.
Personal information about the respondents (n = 278).
| Variable | n. (%) |
|---|---|
| Gender | |
| Female | 204 (73.38) |
| Male | 74 (26.62) |
| Type of hospital | |
| General hospitals | 130 (46.76) |
| Maternity/maternal and child health hospitals | 97 (34.89) |
| Children’s hospitals | 51 (18.35) |
| Hospital level | |
| Tertiary | 266 (95.68) |
| Secondary | 9 (3.24) |
| Other | 3 (1.08) |
| The number of patients in the neonatal unit | |
| <20 | 11 (3.96) |
| 20–49 | 117 (42.09) |
| 50–99 | 73 (26.26) |
| 100–199 | 59 (21.22) |
| ≥200 | 18 (6.47) |
| Professional titles | |
| Senior | 211 (75.90) |
| Intermediate | 64 (23.02) |
| Primary | 3 (1.08) |
| Years of working | |
| <5 | 4 (1.44) |
| 5–9 | 18 (6.47) |
| 10–19 | 101 (36.33) |
| ≥20 | 155 (55.76) |
Table 2.
Overall status of awareness about neonatal lactose intolerance and some information about this disease in their hospitals (n = 278).
Table 2.
Overall status of awareness about neonatal lactose intolerance and some information about this disease in their hospitals (n = 278).
| Variable | n. (%) |
|---|---|
| Awareness about neonatal lactose intolerance | |
| Complete understanding | 78 (28.06) |
| Partial understanding | 169 (60.79) |
| Preliminary understanding | 30 (10.79) |
| A limited understanding | 1 (0.36) |
| Incomprehension | 0 (0) |
| The percentage of neonatal lactose intolerance patients in outpatient clinics (%) | |
| <20 | 160 (57.55) |
| 20–39.99 | 98 (35.25) |
| 40–59.99 | 16 (5.76) |
| ≥60 | 4 (1.44) |
| Is neonatal lactose intolerance more common in full-term or preterm infants? | |
| Full-term infants | 31 (11.15) |
| Preterm infants | 155 (55.76) |
| Full-term and preterm infants are equal | 92 (33.09) |
| Do you think neonatal lactose intolerance is easy to ignore in clinical work? | |
| Yes | 236 (84.89) |
| No | 42 (15.11) |
| If you encountered newborns with diarrhea, bloating, emesis, or unexplained crying, would you test for lactose intolerance? | |
| Yes | 59 (21.22) |
| No | 219 (78.78) |
Table 3.
Status of awareness about neonatal lactose intolerance etiology and symptoms (n = 278).
| Variable | n. (%) |
|---|---|
| Awareness of the etiology of neonatal lactose intolerance | |
| Developmental lactose intolerance | 246 (88.49) |
| Secondary lactase intolerance | 29 (10.43) |
| Drug factors | 2 (0.72) |
| Intestinal inflammation | 1 (0.36) |
| The most common symptoms of neonatal lactose intolerance | |
| Diarrhea | 142 (51.08) |
| Bloating, milk regurgitation, or emesis | 71 (25.54) |
| Unexplained crying | 36 (12.85) |
| Stool with milk flap or foam | 15 (5.40) |
| Increased venting | 14 (5.04) |
| Other symptoms of neonatal lactose intolerance (more than one answer is acceptable) | |
| Chronic diarrhea and severe bloody stool | 252 (90.65) |
| Malnutrition | 269 (96.76) |
| Anemia | 149 (53.60) |
| Abnormal bone metabolism | 139 (50.00) |
| Intestinal colic | 259 (93.17) |
| Oral ulcers, arrhythmias, and eczema | 74 (26.62) |
Table 4.
Status of awareness about neonatal lactose intolerance diagnoses and treatments (n = 278).
| Variable | n. (%) |
|---|---|
| The most common method for diagnostic neonatal lactose intolerance in your hospital (more than one answer is acceptable) | |
| Hydrogen breath test | 29 (10.43) |
| Lactose tolerance test | 30 (10.79) |
| Reducing sugar and pH determination of stool | 71 (25.54) |
| Qualitative test for urinary galactose | 78 (28.06) |
| Jejunum mucosal biopsy | 13 (4.68) |
| Genetic test | 22 (7.91) |
| Could not test | 137 (49.28) |
| When lactose intolerance occurs in newborns, which method do you prefer to use in addition to the conventional symptomatic drugs? | |
| Exogenous lactase | 263 (94.60) |
| Lactose-free formula | 14 (5.04) |
| Other | 1 (0.36) |
| When neonatologists encounter neonates with diarrhea, abdominal distension, or unexplained crying that does not respond well to conventional treatment, lactase can be added as an adjunctive therapy | |
| No | 1 (0.36) |
| Yes | 253 (91.01) |
| Not sure. I’ll decide after further examination | 24 (8.63) |
Table 5.
Status of awareness about lactase (n = 278).
| Variable | n. (%) |
|---|---|
| Awareness of indications for the use of lactase | |
| Complete understanding | 64 (23.02) |
| Partial understanding | 174 (62.59) |
| Preliminary understanding | 38 (13.67) |
| A limited understanding | 2 (0.72) |
| Incomprehension | 0 (0) |
| Awareness of methods and treatment for the use of lactase | |
| Complete understanding | 72 (25.90) |
| Partial understanding | 164 (58.99) |
| Preliminary understanding | 38 (13.67) |
| A limited understanding | 4 (1.44) |
| Incomprehension | 0 (0) |
| How long the lactase is used in newborns diagnosed with secondary lactase intolerance? | |
| 3–5 days | 7 (2.52) |
| 5–7 days | 29 (10.43) |
| More than 2 weeks and symptoms improved | 242 (87.05) |
| Do you give prophylactic supplementation of lactase to newborns at high risk of lactose intolerance? | |
| Frequently | 96 (34.53) |
| Occasionally | 115 (41.37) |
| Supplementation of lactase are only given to newborns diagnosed with lactose intolerance | 67 (24.10) |
| Which lactase do you think is more suitable for lactose-intolerant newborns? | |
| Liquid | 261 (93.88) |
| Solid | 6 (2.16) |
| Both are fine | 11 (3.96) |
Table 6.
Comparison of awareness about neonatal lactose intolerance among neonatologists in three different types of hospitals.
Table 6.
Comparison of awareness about neonatal lactose intolerance among neonatologists in three different types of hospitals.
| Items | General Hospitals (n = 130) | Maternity/Maternal and Child Health Hospitals (n = 97) | Children’s Hospitals (n = 51) | p |
|---|---|---|---|---|
| Males, n (%) | 32 (24.62) | 30 (30.93) | 12 (23.53) | 0.487 |
| Intermediate and senior titles, n (%) | 90 (69.23) | 79 (81.44) | 42 (82.35) | 0.051 |
| Works in a tertiary hospital, n (%) | 126 (96.29) | 91 (93.81) | 49 (96.08) | 0.443 * |
| Their hospital can test for lactose intolerance, n (%) | 70 (53.85) | 45 (46.39) | 26 (50.98) | 0.539 |
| Completely understand the etiology of neonatal lactose intolerance, n (%) | 120 (92.31) | 83 (85.57) | 43 (84.31) | 0.291 * |
| It is believed that newborns with diarrhea, bloating, emesis or unexplained crying are tested for lactose intolerance, n (%) | 30 (23.08) | 16 (16.49) | 13 (25.49) | 0.708 |
| It is believed that exogenous lactase is more suitable for lactose intolerance than lactose-free formula, n (%) | 121 (93.08) | 92 (94.85) | 50 (98.04) | 0.726 * |
| Completely understand indications for the use of lactase, n (%) | 34 (26.15) | 18 (18.56) | 12 (23.53) | 0.498 * |
| It is believed that the lactase should be used for ≥2 weeks in newborns diagnosed with secondary lactase intolerance, n (%) | 116 (89.23) | 78 (80.41) | 48 (94.12) | 0.016 * |
| It is believed that liquid lactase is more suitable for newborns with lactose intolerance, n (%) | 90 (92.78) | 90 (92.78) | 51 (100.00) | 0.406 * |
* Fisher’s exact.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Wang, Z.; Liu, L.; Yu, C.; Tang, W.; Ding, X.; Hu, X.; Shi, Y. Awareness about Neonatal Lactose Intolerance among Chinese Neonatologists in Outpatient Settings: A Multi-Center Survey. Children 2024, 11, 1014. https://doi.org/10.3390/children11081014
AMA Style
Wang Z, Liu L, Yu C, Tang W, Ding X, Hu X, Shi Y. Awareness about Neonatal Lactose Intolerance among Chinese Neonatologists in Outpatient Settings: A Multi-Center Survey. Children. 2024; 11(8):1014. https://doi.org/10.3390/children11081014
Chicago/Turabian StyleWang, Zhengli, Liting Liu, Chao Yu, Wenyan Tang, Xiangping Ding, Xiangwen Hu, and Yuan Shi. 2024. "Awareness about Neonatal Lactose Intolerance among Chinese Neonatologists in Outpatient Settings: A Multi-Center Survey" Children 11, no. 8: 1014. https://doi.org/10.3390/children11081014
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.
